SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

BACKGROUND: Genetically distinct viral variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been recorded since January 2020. The introduction of global vaccine programs has contributed to lower COVID-19 hospitalisation and mortality rates, particularly in developed countrie...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Anupriya, Akerman, Anouschka, Milogiannakis, Vanessa, Silva, Mariana Ruiz, Walker, Gregory, Stella, Alberto Ospina, Kindinger, Andrea, Angelovich, Thomas, Waring, Emily, Amatayakul-Chantler, Supavadee, Roth, Nathan, Manni, Sandro, Hauser, Thomas, Barnes, Thomas, Condylios, Anna, Yeang, Malinna, Wong, Maureen, Jean, Tyra, Foster, Charles S.P., Christ, Daniel, Hoppe, Alexandra Carey, Munier, Mee Ling, Darley, David, Churchill, Melissa, Stark, Damien J., Matthews, Gail, Rawlinson, William D., Kelleher, Anthony D., Turville, Stuart G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482529/
https://www.ncbi.nlm.nih.gov/pubmed/36130476
http://dx.doi.org/10.1016/j.ebiom.2022.104270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482529/
https://www.ncbi.nlm.nih.gov/pubmed/36130476
http://dx.doi.org/10.1016/j.ebiom.2022.104270

Ejemplares similares